Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Dow
Baxter
McKinsey
Merck

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Cytisine

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Cytisine: Sponsors, patents, clinical trial progress

Cytisine is an investigational drug.

There have been 10 clinical trials for Cytisine. The most recent clinical trial was a Phase 1 trial, which was initiated on February 1st 2017.

The most common disease conditions in clinical trials are HIV Infections, Alcohol Drinking, and Inflammation. The leading clinical trial sponsors are Achieve Life Sciences, University of Auckland, New Zealand, and National Institute on Alcohol Abuse and Alcoholism (NIAAA).

There are two hundred and thirty-seven US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Cytisine
TitleSponsorPhase
Varenicline Versus Cytisine for Smoking Cessation in Primary Care SettingHarvard Medical SchoolPhase 3
Varenicline Versus Cytisine for Smoking Cessation in Primary Care SettingMassachusetts General HospitalPhase 3
Varenicline Versus Cytisine for Smoking Cessation in Primary Care SettingUniversity of Ljubljana School of Medicine, SloveniaPhase 3

See all Cytisine clinical trials

Clinical Trial Summary for Cytisine

Top disease conditions for Cytisine
Top clinical trial sponsors for Cytisine

See all Cytisine clinical trials

US Patents for Cytisine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Cytisine   Start Trial Methods and compositions for treating infection UNIVERSITY OF ROCHESTER (Rochester, NY) UNIVERSITY OF KANSAS (Lawrence, KS)   Start Trial
Cytisine   Start Trial Nicotinic attenuation of CNS inflammation and autoimmunity Dignity Health (San Francisco, CA)   Start Trial
Cytisine   Start Trial Dietary supplements and formulations Eastern Vision Limited (Wanchai, HK)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Cytisine

Drugname Country Document Number Estimated Expiration Related US Patent
Cytisine World Intellectual Property Organization (WIPO) 2014052836 2032-09-27   Start Trial
Cytisine Canada 2736871 2028-09-11   Start Trial
Cytisine World Intellectual Property Organization (WIPO) 2010030887 2028-09-11   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
AstraZeneca
Mallinckrodt
Colorcon
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.